(Q43015003)

12 November 2017

0 references

Outcome following percutaneous coronary intervention: not, so far, in our genes (English)

1 reference

12 November 2017

Keavney B

1

1 reference

PMC publication ID

1767596

12 November 2017

language of work or name

English

0 references

publication date

1 March 2003

1 reference

12 November 2017

1 reference

12 November 2017

89

1 reference

12 November 2017

3

1 reference

12 November 2017

247-248

1 reference

Prospective evaluation of the effect of an angiotensin I converting enzyme gene polymorphism on the long term risk of major adverse cardiac events after percutaneous coronary intervention

12 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1767596

Angiotensin converting enzyme insertion or deletion polymorphism and coronary restenosis: meta-analysis of 16 studies

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1767596

Platelet glycoprotein IIIa polymorphisms and risk of coronary stent thrombosis

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1767596

Platelet glycoprotein receptor IIIa polymorphism PLA1/PLA2 and coronary risk: a meta-analysis.

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1767596

Effect of high dose angiotensin-converting enzyme inhibition on restenosis: final results of the MARCATOR Study, a multicenter, double-blind, placebo-controlled trial of cilazapril. The Multicenter American Research Trial With Cilazapril After Angio

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1767596

Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1767596

Large-scale test of hypothesised associations between the angiotensin-converting-enzyme insertion/deletion polymorphism and myocardial infarction in about 5000 cases and 6000 controls. International Studies of Infarct Survival (ISIS) Collaborators

1 December 2018

1 reference

12 December 2020

PlA polymorphism of glycoprotein IIIa and risk of adverse events after coronary stent placement

1 reference

12 December 2020

Reduced inhibition by abciximab in platelets with the PlA2 polymorphism

1 reference

12 December 2020

Evidence that angiotensin-converting enzyme inhibitor use diminishes the need for coronary revascularization after stenting

1 reference

12 December 2020

PlA polymorphism of platelet glycoprotein IIIa and risk of restenosis after coronary stent placement

1 reference

12 December 2020

Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: a multicenter, randomized, double-blind placebo-controlled trial. Multicenter Euro

1 reference

12 December 2020

Identifiers

DOI

10.1136/HEART.89.3.247

1 reference

12 November 2017

1 reference

PMC publication ID

1767596

12 November 2017

PubMed publication ID

12591817

1 reference

PMC publication ID

1767596